-
161
Initial Treatment Modalities in Patients with Newly Diagnosed Primary Lung Cancer in Japan
Published 2025-01-01Get full text
Article -
162
Cardiopulmonary Profile in Streptozotocin-Induced Type 1 Diabetic Rats during Systemic Endotoxemia
Published 2013-01-01Get full text
Article -
163
Historical rainstorm in Hong Kong on 7–8 September 2023: Diagnosis, forecasting and nowcasting
Published 2025-01-01Get full text
Article -
164
Atomistic behavior of Cu–Cu solid-state bonding in polycrystalline Cu with high-density boundaries
Published 2025-02-01Get full text
Article -
165
-
166
-
167
Association of Tobacco Smoking with Physical Fitness of Military Males in Taiwan: The CHIEF Study
Published 2020-01-01Get full text
Article -
168
Microcontroller-Based Intravenous Fluid Monitoring System Design
Published 2024-06-01Get full text
Article -
169
Non-Linear Control of Interleaved Boost Converter Using Disturbance Observer-Based Approach
Published 2025-01-01Get full text
Article -
170
Oral Glutamine Supplement Inhibits Ascites Formation in Peritoneal Carcinomatosis Mouse Model
Published 2013-01-01Get full text
Article -
171
-
172
-
173
A Transcriptomic Dataset of Liver Tissues from Global and Liver-Specific Bmal1 Knockout Mice
Published 2025-02-01Get full text
Article -
174
-
175
-
176
-
177
-
178
Clinical outcomes after immune checkpoint inhibitor-associated acute kidney injury: a cohort study
Published 2025-02-01Get full text
Article -
179
Comparison of Clinical Characteristics and Mortality Outcome in Critical COVID-19 Patients Infected with Alpha and Omicron Variants
Published 2025-01-01“…The Alpha group had a higher body mass index, had a longer ICU stay, and included more patients with acute respiratory distress syndrome, and the Omicron group included more active smokers, had more comorbidities, had worse initial laboratory data (including higher white blood cell counts, prothrombin time [PT], activated partial prothrombin time, blood urine nitrogen levels, and creatine levels), and had higher in-hospital mortality rates (40.6% vs 15.2%, p = 0.004). …”
Get full text
Article -
180
The potential synergistic effect of combining doxorubicin with vorinostat in urothelial carcinoma therapy
Published 2025-01-01Get full text
Article